• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Cardinal Health Inc.

    6/23/26 8:21:44 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email
    cdns-20260623
    FalseFalse00007213710000721371iso4217:USDxbrli:pure0000721371cdns:EBP062Member2025-01-012025-12-3100007213712025-01-012025-12-310000721371cdns:EBP062Member2025-12-310000721371cdns:EBP062Member2024-12-310000721371cdns:EBP062Member2024-01-012024-12-310000721371cdns:EBP062Member2023-12-310000721371cdns:EBP062Membersrt:MinimumMember2025-01-012025-12-310000721371cdns:EBP062Membersrt:MaximumMember2025-01-012025-12-310000721371cdns:EBPEmployerMatchingContributionMember2025-01-012025-12-310000721371cdns:EBPDiscretionaryProfitSharingContributionMembercdns:EBP062Member2025-01-012025-12-310000721371srt:MinimumMembercdns:EBPNonHighlyCompensatedParticipantContributionsMembercdns:EBP062Member2025-01-012025-12-310000721371srt:MaximumMembercdns:EBPNonHighlyCompensatedParticipantContributionsMembercdns:EBP062Member2025-01-012025-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2025-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2025-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMembercdns:EBP062Member2025-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMembercdns:EBP062Member2025-12-310000721371us-gaap:CashAndCashEquivalentsMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMembercdns:EBP062Member2025-12-310000721371us-gaap:CashAndCashEquivalentsMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMembercdns:EBP062Member2025-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2024-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2024-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMembercdns:EBP062Member2024-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMembercdns:EBP062Member2024-12-310000721371us-gaap:CashAndCashEquivalentsMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMembercdns:EBP062Member2024-12-310000721371us-gaap:CashAndCashEquivalentsMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMembercdns:EBP062Member2024-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2025-01-012025-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2025-01-012025-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2024-01-012024-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2024-01-012024-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel1Member2025-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2025-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2025-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel1Member2025-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2025-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2025-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel1Member2025-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2025-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2025-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMembercdns:EBP062Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel1Member2024-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2024-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2024-12-310000721371us-gaap:MutualFundMembercdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember2024-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2024-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2024-12-310000721371us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMembercdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel1Member2024-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel2Member2024-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel3Member2024-12-310000721371cdns:EBP062Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310000721371us-gaap:DefinedBenefitPlanCommonCollectiveTrustMembercdns:EBP062Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-12-310000721371cdns:EBP062Memberus-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMember2025-12-310000721371cdns:EBP062MemberMutual Funds | Dodge & Cox Stock Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2030 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2040 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2035 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2045 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2050 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2055 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2025 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | Vanguard Total International Stock Index Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2060 Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement Income Fund2025-12-310000721371cdns:EBP062MemberMutual Funds | JPMorgan SmartRetirement 2065 Fund2025-12-310000721371cdns:EBP062MemberCommon collective trusts | Fidelity Management Trust Company 12025-12-310000721371cdns:EBP062MemberCommon collective trusts | Vanguard Fiduciary Trust Company 12025-12-310000721371cdns:EBP062MemberCommon collective trusts | Vanguard Fiduciary Trust Company 22025-12-310000721371cdns:EBP062MemberCommon collective trusts | FIAM Trust Company2025-12-310000721371cdns:EBP062MemberCommon collective trusts | Fidelity Management Trust Company 22025-12-310000721371cdns:EBP062MemberCommon collective trusts | Vanguard Fiduciary Trust Company 42025-12-310000721371cdns:EBP062MemberCommon collective trusts | SEI Trust Company2025-12-310000721371cdns:EBP062MemberCommon shares | Cardinal Health, Inc.2025-12-310000721371Loans | Participant loanssrt:MinimumMembercdns:EBP062Member2025-01-012025-12-310000721371Loans | Participant loanssrt:MaximumMembercdns:EBP062Member2025-01-012025-12-310000721371cdns:EBP062MemberLoans | Participant loans2025-12-31
    Table of Contents

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 11-K
    þANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2025
    or
    oTRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from ________ to ________
    Commission File Number 1-11373
    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:
    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    B.Name of the issuer of the securities held pursuant to the plan and the address of its principal executive office:
    Cardinal Health, Inc.
    7000 Cardinal Place
    Dublin, Ohio 43017




    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Financial Statements and Supplemental Schedule
    Years Ended December 31, 2025 and 2024
    Table of Contents
    Report of Independent Registered Public Accounting Firm
    1
    Financial Statements:
    Statements of Net Assets Available for Benefits
    2
    Statements of Changes in Net Assets Available for Benefits
    3
    Notes to Financial Statements
    4
    Supplemental Schedule*:
    Schedule H, Line 4i on Form 5500: Schedule of Assets (Held at End of Year)
    12
    Signature
    13
    Exhibit:
    Consent of Independent Registered Public Accounting FirmExhibit 23.1
    *All other financial schedules required by Section 2520.103-10 of the U.S. Department of Labor’s Annual Reporting and Disclosure Requirements under the Employee Retirement Income Security Act of 1974, as amended, have been omitted because they are not applicable.



    Table of Contents
    Report of Independent Registered Public Accounting Firm
    To the Plan Participants and the Plan Administrator of Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Opinion on the Financial Statements
    We have audited the accompanying statements of net assets available for benefits of Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico (the Plan) as of December 31, 2025 and 2024, and the related statements of changes in net assets available for benefits for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2025 and 2024, and the changes in its net assets available for benefits for the years then ended, in conformity with U.S. generally accepted accounting principles.
    Basis for Opinion
    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    Supplemental Schedule Required by ERISA
    The accompanying supplemental schedule of assets (held at end of year) as of December 31, 2025 (referred to as the “supplemental schedule”), has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
    /s/ Ernst & Young LLP
    We have served as the Plan's auditor since 2002.
    Grandview Heights, Ohio
    June 23, 2026

    1

    Table of Contents
    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Statements of Net Assets Available for Benefits
    December 31, 2025 and 2024
     20252024
    Assets
    Plan’s interest in Stable Value Master Trust$6,517,658 $6,133,176 
    Investments at fair value55,506,644 44,092,527 
    Accrued income492 23,509 
    Non-interest bearing cash11,655 39,965 
    Receivables:
      Notes receivable from participants1,846,104 1,630,628 
      Company contributions12,560 13,291 
          Total receivables1,858,664 1,643,919 
    Net assets available for benefits$63,895,113 $51,933,096 
    The accompanying notes are an integral part of these financial statements.
    2

    Table of Contents
    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Statements of Changes in Net Assets Available for Benefits
    For the Years Ended December 31, 2025 and 2024
    20252024
    Additions to net assets attributed to:
    Investment income:
    Interest and dividends$595,462 $555,491 
    Net appreciation in fair value of investments10,214,768 6,617,239 
    Plan's interest in Stable Value Master Trust's net investment income215,841 182,173 
    Total investment income 11,026,071 7,354,903 
    Interest income on notes receivable from participants141,356 112,388 
    Contributions:
    Company1,193,842 1,196,376 
    Participant2,199,728 2,215,957 
    Rollovers— 1,030 
    Total contributions3,393,570 3,413,363 
    Total additions14,560,997 10,880,654 
    Deductions from net assets attributed to:
    Benefits paid to participants2,550,206 5,029,921 
    Administrative expenses48,774 41,026 
    Total deductions2,598,980 5,070,947 
    Net increase11,962,017 5,809,707 
    Net assets available for benefits:
    Beginning of year51,933,096 46,123,389 
    End of year$63,895,113 $51,933,096 
    The accompanying notes are an integral part of these financial statements.
    3

    Table of Contents

    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Notes to Financial Statements
    December 31, 2025 and 2024
    1. Description of Plan
    General
    The Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico (the “Plan”) is a defined contribution plan, covering substantially all employees of certain subsidiaries of Cardinal Health, Inc. (the “Company”) residing in Puerto Rico. Employees who are covered by a collective bargaining agreement are not eligible to participate, unless the agreement provides for participation. Eligible employees participate upon their date of hire. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).

    A trust with a bank in Puerto Rico was established for the Plan. In addition, certain assets of the Plan are held within the Cardinal Health Stable Value Fund (the “Stable Value Master Trust”), which was established for the Plan and certain other plans of the Company. See Note 3 for more information regarding the Stable Value Master Trust.

    Effective January 1, 2024, the Plan was amended and restated in compliance with the Internal Revenue Code for a New Puerto Rico (2011), as amended (the “Code”).

    The description of the Plan provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.

    Administration
    The Company’s Financial Benefit Plans Committee (the “Committee”) is the Plan administrator and is responsible for the general operation and administration of the Plan.

    Banco Popular de Puerto Rico is the trustee of the Plan. Principal Financial Group and certain of its affiliates perform the recordkeeping and asset custodian duties.

    Contributions
    Contributions that may be made to the Plan include participant elective contributions, rollover contributions, Company matching, discretionary employer, and discretionary special contributions.

    Participants may elect to contribute a percentage of their eligible compensation (subject to certain limitations), as defined by the Plan document. Participants who have or will attain at least age 50 by the end of the plan year may elect to contribute up to an additional $1,500 in each of 2025 and 2024 as a catch-up contribution. Participants may also roll over amounts representing distributions from other qualified plans.

    The Company match is 200% of each participant’s compensation deferral contributions that do not exceed 1% of the participant’s compensation, and 50% of each participant’s compensation deferral contributions that exceed 1% of the participant’s compensation but that do not exceed 5% of the participant’s compensation.

    In addition, the Company may elect to make discretionary employer contributions and/or discretionary special contributions. Discretionary employer contributions are allocated to participants based generally on their proportionate share of total eligible compensation and eligible compensation above the Social Security taxable wage base amount for the year of allocation.

    The Plan’s discretionary employer contribution is determined at the discretion of the Human Resources and Compensation Committee of the Company’s Board of Directors or such other committee, entity, or person authorized by the Human Resources and Compensation Committee for such purposes. To be eligible for the discretionary employer contribution, participants generally must be employed on the last day of the Company’s fiscal year, June 30.

    The discretionary employer contribution is calculated on eligible compensation received during the Company’s fiscal year ending within the Plan year for which the discretionary employer contribution is made to the Plan. No discretionary employer contributions were made to the Plan for the years ended December 31, 2025 and 2024.

    4

    Table of Contents
    Notes to Financial Statements
    The Plan’s discretionary special contributions, if any, are allocated to the participants in the eligible group ratably based on their proportionate share of the total eligible compensation in that group. No discretionary special contributions were made to the Plan for the years ended December 31, 2025 and 2024.

    Participants direct the investment of their contributions into various investment options offered by the Plan. The Company’s matching, discretionary employer and discretionary special contributions, if any, are also invested as directed by participants.

    Participant Accounts
    Each participant’s account is credited with the participant’s elective contributions, any rollover contributions made by the participant and allocations of the Company’s contributions and Plan earnings or losses. A participant is entitled to the benefit provided from the participant’s vested account balance.

    Vesting
    Participants are 100% vested immediately in their elective deferral, rollover, and Company matching contributions, plus actual earnings thereon. A participant is 100% vested in the Company’s discretionary employer and discretionary special contributions after three years of vesting service, or if the participant dies, becomes totally disabled, or reaches retirement age, as defined in the Plan document, while employed by the Company. The Plan provides for the partial vesting of the Company contributions to participants with more than one year, but less than three years, of vesting service, who were terminated as part of a designated reduction in workforce, as defined in the Plan document.

    Forfeitures
    Non-vested account balances are generally forfeited either upon full distribution of vested balances or completion of five consecutive one-year breaks in service, as defined in the Plan document. Forfeitures are either used to reduce Company contributions to the Plan or to pay reasonable expenses of the Plan as determined by the Committee.

    Forfeitures used to reduce Company contributions and to pay reasonable expenses of the Plan were $7,937 and $11,862 during 2025 and 2024, respectively. At December 31, 2025 and 2024, forfeited non-vested accounts were $125 and $3,909, respectively.

    Administrative Expenses
    Administrative expenses are paid by the Company or from the assets of the Plan. General expenses paid from the Plan’s assets are allocated among participant accounts to the extent not paid from forfeitures, except for fees for loans, withdrawals, and Qualified Domestic Relations Orders, which are paid from the account of the participant incurring the expense.

    Participant Loans
    Participants may borrow from their fund accounts a minimum of $1,000 up to a maximum equal to the lesser of $50,000, less the highest outstanding loan balance during the prior 12 months or 50% of their vested account balance. Loan terms primarily range from 1 to 5 years for general purposes, or up to 15 years for the purchase of a primary residence. Participant loans are secured by 50% of the vested balance in the participant’s account as of the date of the loan and bear interest at a reasonable rate, as established by the Committee, currently Prime plus 1%, which is set for the life of the loan. Interest rates for new loans are subject to change on a monthly basis. Loan repayments, including interest and applicable loan fees, are generally repaid through payroll deductions.

    Payment of Benefits
    Upon termination of employment, death, retirement, or total disability, distributions are generally made in the form of a lump-sum payment or installments. In addition, the Plan includes a provision for participants to make withdrawals from their rollover contributions account at any time, elective contributions account under certain hardship circumstances, or their account after attaining age 59 1/2, as defined in the Plan document. Required qualified joint and survivor annuity payment options are preserved for the portion of the participant accounts transferred to the Plan from a money purchase pension plan, if any.
    5

    Table of Contents
    Notes to Financial Statements
    2. Summary of Significant Accounting Policies
    Basis of Presentation
    The financial statements of the Plan are prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”).

    Use of Estimates
    The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes and supplemental schedules. Actual results could differ from those estimates.

    Investment Valuation and Income Recognition
    Plan investments, except for fully benefit-responsive investment contracts (see Note 3), are reported at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 4 for discussion of fair value measurements.

    Purchases and sales of securities are recorded on a trade-date basis using fair market value, except for those investments in investment contracts that are transacted at contract value. Dividends are recorded on the ex-dividend date. Interest is recorded on the accrual basis. Net appreciation includes the Plan’s gains and losses on investments bought and sold, as well as held, during the year.

    Contributions
    Contributions from Plan participants, and the related matching contributions from the Company, are recorded in the year in which the employee contributions are withheld from compensation.

    Notes Receivable from Participants
    Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance, plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. If a participant ceases to make loan repayments and the Plan sponsor deems the participant loan to be a distribution, the participant loan balance is retained as a defaulted loan amount until a distributable event occurs, at which time the loan amount is offset from the value of the account.

    Payment of Benefits
    Benefit payments are recorded when paid.
    6

    Table of Contents
    Notes to Financial Statements
    3. Assets Held in the Stable Value Master Trust
    Certain of the Plan’s investments are held in the Stable Value Master Trust, which was established for the investment of assets of the Plan and other Company-sponsored retirement plans. Each participating plan’s interest in the investment funds (i.e., separate accounts) of the Stable Value Master Trust is based on account balances of the participants and their elected investment funds. The Stable Value Master Trust’s assets are allocated among the participating plans by assigning to each plan those transactions (primarily contributions, benefit payments, and plan-specific expenses) that can be specifically identified and by allocating among all plans, in proportion to the fair value of the assets assigned to each plan, income and expenses resulting from the collective investment of the assets of the Stable Value Master Trust. The Plan’s interest in the Stable Value Master Trust’s net investment income presented in the Statements of Changes in Net Assets Available for Benefits consists of the unrealized and realized gains (losses) and the earnings on those investments.

    The Stable Value Master Trust holds synthetic investment contracts which meet the fully benefit-responsive investment contract criteria and therefore are reported at contract value. Contract value is the relevant measure for fully benefit-responsive investment contracts, because this is the amount received by participants if they were to initiate permitted transactions under the terms of the Plan. Contract value represents contributions made under each contract, plus earnings, less participant withdrawals, and administrative expenses.

    The Plan owns the underlying investments of the synthetic investment contracts. A synthetic investment contract includes a wrapper contract, which is an agreement for the wrap issuer, such as a bank or insurance company, to make payments to the Plan in certain circumstances. The wrapper contract typically includes certain conditions and limitations on the underlying assets owned by the Plan. Synthetic investment contracts are designed to accrue interest based on crediting rates established by the contract issuers.

    The synthetic investment contracts held by the Plan include wrapper contracts which provide a guarantee that the credit rate will not fall below 0%. Cash flow volatility (e.g., timing of benefit payments), as well as asset underperformance, can be passed through to the Plan through adjustments to future contract crediting rates. Formulas are provided in the contracts that adjust renewal crediting rates to recognize the difference between fair value and the book value of the underlying assets. Crediting rates are reviewed quarterly for resetting.

    The Plan’s ability to receive amounts due in accordance with fully benefit-responsive investment contracts is dependent on the third-party issuers’ ability to meet their financial obligations. The issuers’ ability to meet their contractual obligations may be affected by future economic and regulatory developments.

    Certain events might limit the ability of the Plan to transact at contract value with the contract issuers. These events may be different under each contract. Examples of such events include the following:
    •Plan disqualification under the Code;
    •Establishment of a defined contribution plan by the Company that competes for participant contributions;
    •Material amendments to the Plan or administration as to investment options, transfer procedures, or withdrawals;
    •Company’s inducement to participants to withdraw or transfer funds from the contract;
    •Termination or partial termination of the Plan;
    •Group termination, layoff, early retirement incentive program, or other downsizing by the Company;
    •Merger or consolidation of the Plan with another plan or spin-off of any portion of the Plan’s assets to another Plan; and
    •Any changes in law, regulation, ruling, or administrative or judicial position that, in the issuer’s reasonable determination, could result in substantial disbursements from the contract.
    No events are probable of occurring that might limit the ability of the Plan to transact at contract value with the contract issuers and that also would limit the ability of the Plan to transact at contract value with the participants.

    In addition, certain events allow the issuers to terminate the contacts with the Plan and settle at an amount different from contract value. Those events may be different under each contract. Examples of such events include the following:

    •The investment manager or trustee breaches any of its material obligations under the agreement;
    •Any representation of the investment manager is or becomes untrue in any material respect;
    •The investment manager with respect to the contract is terminated, unless a qualified professional manager is duly appointed and is agreed to by the issuer;
    •The issuer determines that the execution, delivery, or performance of the contract constitutes or will constitute a prohibited transaction;
    •Failure to pay amounts due to the issuer; and
    •Termination of the Plan, or disqualification of the trust.
    Each investment contract is subject to early termination penalties that may be significant. There are no reserves against contract value for credit risk of the contract issuers or other matters.
    7

    Table of Contents
    Notes to Financial Statements
    The Stable Value Master Trust also holds a stable value common collective trust that is composed primarily of fully benefit-responsive investment contracts and is valued at the net asset value of units of the collective trust. The common collective trust is designed to deliver safety and stability by preserving principal and accumulating earnings. The net asset value is used as a practical expedient to estimate fair value. This practical expedient would not be used if it is determined to be probable that the fund will sell the investment for an amount different from the reported net asset value. Participant transactions (purchases and sales) may occur daily. If the Plan initiates a full redemption of the collective trust, the issuer reserves the right to require a one-year notice to ensure that securities liquidations will be carried out in an orderly business manner. The Plan has no contractual obligations to further invest in the fund.

    The assets held in the Stable Value Master Trust were as follows for the years ended December 31, 2025 and 2024:
    2025
     Master Trust BalancePlan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Fully benefit-responsive synthetic investment contracts - at contract value$345,329,447 $6,265,161 2 %
    Common collective trusts - at fair value14,211,069 257,825 2 %
    Total Master Trust investments359,540,516 6,522,986 2 %
    Cash and pending activity(293,669)(5,328)2 %
    Total Master Trust net assets$359,246,847 $6,517,658 2 %
    2024
     Master Trust BalancePlan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Fully benefit-responsive synthetic investment contracts - at contract value$348,635,756 $5,974,834 2 %
    Common collective trusts - at fair value9,575,564 164,104 2 %
    Total Master Trust investments358,211,320 6,138,938 2 %
    Cash and pending activity(336,174)(5,762)2 %
    Total Master Trust net assets$357,875,146 $6,133,176 2 %
    The investment income of the Stable Value Master Trust was as follows for the years ended December 31:
     2025
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Net investment income$11,831,386 $215,841 2 %
    Total investment income11,831,386 215,841 2 %
     2024
     Master Trust
    Balance
    Plan's Interest in Master Trust Balance ($)Plan's Interest in Master Trust Balance (%)
    Net investment income$11,133,977 $182,173 2 %
    Total investment income11,133,977 182,173 2 %
    8

    Table of Contents
    Notes to Financial Statements
    4. Fair Value Measurements
    Accounting Standards Codification (“ASC”) 820, Fair Value Measurement, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

    The three levels of the fair value hierarchy under ASC 820 are described as follows:
    Level 1:    Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.
    Level 2:    Inputs to the valuation methodology include:
    •quoted prices for similar assets or liabilities in active markets;
    •quoted prices for identical or similar assets or liabilities in inactive markets;
    •inputs other than quoted prices that are observable for the asset or liability; and
    •inputs that are derived principally from or corroborated by observable market data by correlation or other means.
    If the asset or liability has a specified (contractual) term, the level 2 input must be observable for substantially the full term of the asset or liability.
    Level 3:    Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
    The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

    Following is a description of the valuation techniques and inputs used for each general type of assets measured at fair value. There have been no changes in the methodologies used at December 31, 2025 and 2024.

    Mutual funds and common shares fair values are determined utilizing quoted market prices reported on the active market on which they are traded.

    The common collective trusts (“CCTs”) are valued utilizing the respective net asset values as reported by such trusts, which are reported at fair value. The net asset value is used as a practical expedient to estimate fair value. The fair value has been determined by the trustee sponsoring the CCT by dividing the trust’s net assets at fair value by its units outstanding at the valuation dates. There are no restrictions as to the redemption of these investments, nor does the Plan have any contractual obligations to further invest in any of these CCTs.

    The preceding methods described may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

    The following tables set forth by level, within the fair value hierarchy, the fair value of the Plan’s assets held outside of the Stable Value Master Trust as of December 31, 2025 and 2024:
     December 31, 2025
     Level 1Level 2Level 3Total
    Mutual funds$21,139,289 $— $— $21,139,289 
    Cardinal Health, Inc., common shares9,365,457 — — 9,365,457 
    Total assets in the fair value hierarchy$30,504,746 $— $— $30,504,746 
      Common collective trusts measured at net asset value25,001,898 
    Total assets at fair value$55,506,644 
    9

    Table of Contents
    Notes to Financial Statements
     December 31, 2024
     Level 1Level 2Level 3Total
    Mutual funds$17,136,052 $— $— $17,136,052 
    Cardinal Health, Inc., common shares5,417,003 — — 5,417,003 
    Total assets in the fair value hierarchy$22,553,055 $— $— $22,553,055 
      Common collective trusts measured at net asset value21,539,472 
    Total assets at fair value$44,092,527 
    10

    Table of Contents
    Notes to Financial Statements
    5. Income Tax Status
    The Plan has received a determination letter from the Puerto Rico Department of Treasury (“PR Treasury”) dated November 28, 2023, stating that the Plan is qualified under Section 1081.01 of the Code and, therefore, the related trust is exempt from taxation. In accordance with applicable PR Treasury requirements, certain amendments to the Plan that did not impact the tax status of the Plan were not considered by PR Treasury in issuing the determination letter. Once qualified, the Plan is required to operate in conformity with the Code to maintain its qualified status. The plan administrator believes the Plan is being operated in compliance with the applicable requirements of the Code and, therefore, believes the Plan is qualified and the related trust is tax-exempt.

    GAAP requires plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position is more likely than not, based on the technical merits, to be sustained upon examination by PR Treasury. The Plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2025 and 2024, there are no uncertain positions taken or expected to be taken. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.
    6. Risks and Uncertainties
    The Plan invests in various investment securities. Investment securities are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Market risks include global events which could impact the value of investment securities, such as pandemic or international conflict. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits.
    7. Plan Termination
    Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of Plan termination, participants will become 100% vested in their accounts.
    8. Related Party and Parties-in-Interest Transactions
    The Plan held $9,365,457 and $5,417,003 of Cardinal Health, Inc. common shares at December 31, 2025 and 2024, respectively.
    Notes receivable from participants, together with the related interest income, qualify as party-in-interest transactions under ERISA because participants are parties in interest to the Plan. These transactions are exempt from the prohibited transaction rules of ERISA.

    11

    Table of Contents

    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Schedule H, Line 4i on Form 5500: Schedule of Assets (Held at End of Year)*
    December 31, 2025
    EIN: 31-0958666 Plan Number: 062
    (a)(b)(c)(e)
     Identity of issuer, borrower, lessor, or similar partyDescription of investment, including maturity
    date, rate of interest, maturity or par value
    Current
    value
    Mutual funds:
    Dodge & Cox Stock Fund3,477,936 
    JPMorgan SmartRetirement 2030 Fund 2,752,218 
    JPMorgan SmartRetirement 2040 Fund 2,923,987 
    JPMorgan SmartRetirement 2035 Fund 2,940,490 
    JPMorgan SmartRetirement 2045 Fund 2,201,197 
    JPMorgan SmartRetirement 2050 Fund 2,428,908 
    JPMorgan SmartRetirement 2055 Fund 1,552,400 
    JPMorgan SmartRetirement 2025 Fund 751,485 
    **Vanguard Total International Stock Index Fund999,517 
    JPMorgan SmartRetirement 2060 Fund600,935 
    JPMorgan SmartRetirement Income Fund 369,801 
    JPMorgan SmartRetirement 2065 Fund 140,415 
    Common collective trusts:
    Fidelity Management Trust CompanyGrowth Company Commingled Pool 10,370,588 
    **Vanguard Fiduciary Trust Company500 Index Trust 6,547,077 
    **Vanguard Fiduciary Trust CompanyExtended Market Index Trust 4,026,859 
    FIAM Trust CompanyCore Plus Commingled Pool1,529,063 
    Fidelity Management Trust CompanyDiversified International Commingled Pool 1,907,394 
    **Vanguard Fiduciary Trust CompanyTotal Bond Market Index Trust 462,627 
    SEI Trust CompanyShort-Term Investment Fund158,290 
    Common shares:
    **Cardinal Health, Inc.Common shares9,365,457 
    Loans:
    **Participant loans
    Various maturity dates, with interest rates ranging from 4.25% to 9.50%
    1,846,104 
    Total$57,352,748 
    *Other columns required by the U.S. Department of Labor’s Annual Reporting and Disclosure Requirements under ERISA have been omitted because they are not applicable.
    **Denotes party-in-interest.

    12

    Table of Contents

    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the members of the Committee have duly caused this annual report to be signed on its behalf by the undersigned thereunto duly authorized.
    Cardinal Health 401(k) Savings Plan for Employees of Puerto Rico
    Date:June 23, 2026/s/ CASEY FORDYCE
    Casey Fordyce
    Financial Benefit Plans Committee Member

    13
    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    4/28/2026Outperform
    William Blair
    1/9/2026Neutral → Buy
    Citigroup
    12/9/2025$243.00Overweight
    Barclays
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $CAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an opera

    5/5/26 4:40:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 11% to $60.9 billionGAAP1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted EPS increased 35% to $3.17Cardinal Health raises and narrows fiscal year 2026 non-GAAP EPS guidance2 to $10.70 to $10.80Cardinal Health reduces debt and completes additional $250 million share repurchase, bringing FY26 repurchase total to $1.0 billionDUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025.Third quarter GAAP operating earn

    4/30/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings

    Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes.DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE:CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care. Advanced therapies are innovative gene-, cell- and tissue-based treatments that target the root cause of disease by repairing, replacing or regenerating damaged cells, offering long-term benefits for many conditions. As more therapies shift to outpat

    4/14/26 7:00:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    SEC Filings

    View All

    SEC Form 11-K filed by Cardinal Health Inc.

    11-K - CARDINAL HEALTH INC (0000721371) (Filer)

    6/23/26 8:21:44 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form 11-K filed by Cardinal Health Inc.

    11-K - CARDINAL HEALTH INC (0000721371) (Filer)

    6/23/26 8:20:53 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SD filed by Cardinal Health Inc.

    SD - CARDINAL HEALTH INC (0000721371) (Filer)

    6/1/26 4:05:13 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Financials

    Live finance-specific insights

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an opera

    5/5/26 4:40:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 11% to $60.9 billionGAAP1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted EPS increased 35% to $3.17Cardinal Health raises and narrows fiscal year 2026 non-GAAP EPS guidance2 to $10.70 to $10.80Cardinal Health reduces debt and completes additional $250 million share repurchase, bringing FY26 repurchase total to $1.0 billionDUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025.Third quarter GAAP operating earn

    4/30/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Leadership Updates

    Live Leadership Updates

    View All

    Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

    DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately. Mr. Kenny has served on the Board since 2007 and as Chairman since 2018. During his tenure on the Board, Mr. Kenny supported the Company through periods of significant transformation, including strategic portfolio evolution and operational improvement initiatives."On behalf of the Board and our management team, we are d

    3/23/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials

    $CAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hall Patricia Hemingway

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    4/17/26 7:26:16 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Information Officer Greene Michelle D. sold $627,387 worth of shares (2,746 units at $228.47), decreasing direct ownership by 18% to 12,230 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    3/3/26 4:11:18 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Financial Officer Alt Aaron E covered exercise/tax liability with 1,914 shares and sold $524,964 worth of shares (2,328 units at $225.50), decreasing direct ownership by 14% to 26,408 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    2/18/26 4:25:35 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Cardinal Health

    William Blair initiated coverage of Cardinal Health with a rating of Outperform

    4/28/26 7:43:38 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/13/24 5:01:02 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    1/30/24 1:39:03 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/14/23 12:37:58 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care